| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.3M | +9.9% |
| Cost of Revenue | $11.4M | -10.9% |
| Gross Profit | $4.0M | +227.7% |
| R&D Expense | $783K | -58.8% |
| SG&A Expense | $3.8M | +30.1% |
| Operating Income | -$1.7M | +64.9% |
| Pre-tax Income | -$4.4M | +38.5% |
| Income Tax | $2K | -87.9% |
| Net Income | -$4.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.1M | +18.8% |
| Inventory | $2.0M | -24.6% |
| Current Assets | $5.9M | -13.1% |
| Total Assets | $13.9M | +1.9% |
| Current Liabilities | $9.7M | -24.8% |
| Total Liabilities | $11.3M | -13.5% |
| Stockholders' Equity | $2.6M | +346.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +73.6% |
| Investing Cash Flow | -$296K | — |
| Financing Cash Flow | -$1.2M | -122.1% |
| +38.6% |
| EPS (Basic) | -$0.17 | +51.4% |
| EPS (Diluted) | -$0.17 | +51.4% |